Tag: Alzheimer
President Biden, in his State of the Union speech, proposed giving Medicare the ability to negotiate lower prices for prescription drugs. I’m assuming the President means not only over-the-counter drugs covered under Part D but also medications administered in a doctor’s office covered under Part B. Medicare sorely needs that ability. While Medicare’s decision to…
Aduhelm, a drug developed recently by Biogen, has raised enormously important issues for Medicare. Biogen’s initial proposed price for Aduhelm was $56,000 per patient per year. Because Aduhelm is administered intravenously by physicians, it would be covered under Medicare Part B. (Medicare Part D covers retail prescription drugs.) While, to date, Medicare has covered virtually…
